Invention Grant
- Patent Title: Alkaloid compounds for treating depression, substance addictions, and indications associated with chronic inflammation
-
Application No.: US15522815Application Date: 2015-11-16
-
Publication No.: US10213438B2Publication Date: 2019-02-26
- Inventor: Jonnie R. Williams
- Applicant: MyMD Pharmaceuticals, Inc.
- Applicant Address: US FL Tampa
- Assignee: MyMD Pharmaceuticals, Inc.
- Current Assignee: MyMD Pharmaceuticals, Inc.
- Current Assignee Address: US FL Tampa
- Agency: Banner & Witcoff, Ltd.
- International Application: PCT/US2015/060887 WO 20151116
- International Announcement: WO2016/081369 WO 20160526
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D401/04 ; A61P37/02 ; A61P35/00 ; A61K31/4439 ; A61K31/444
Abstract:
Alkaloid compounds described herein are useful for treating disorders associated with monoamine oxidase (MAO) activity, such as depression, pain, smoking cessation, and substance addictions, and/or for treating disorders associated with chronic or low-level inflammation. In some examples, compounds are effective for treating cancers, autoimmune disorders, and other disorders associated with inducible nitric oxide synthase (iNOS).
Public/Granted literature
Information query
